Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 314.50
Bid: 316.00
Ask: 317.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.316%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 314.50
MGAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UNIVERSITY OF MANCHESTER PARTNERS WITH MORGAN

5 Aug 2014 09:53

RNS Number : 2716O
Morgan Advanced Materials PLC
05 August 2014
 



 

 

5 August 2014

 

THE UNIVERSITY OF MANCHESTER PARTNERS WITH MORGAN ADVANCED MATERIALS FOR GRAPHENE DEVELOPMENT

 

Morgan Advanced Materials has announced a new joint development agreement with The University of Manchester, aimed at scaling up a new process for manufacturing graphene - a one-atom thick carbon allotrope first isolated at the university ten years ago and for which two Nobel Prizes were awarded.

 

The world's thinnest material and a potent conductor, graphene is also extremely lightweight, chemically inert and has a large surface area which means, with further research and testing, it could change the way we think about electrical and chemical engineering.

 

Bringing together some of the University's leading graphene researchers and Morgan's 150 years of carbon processing expertise, the partnership will explore the full potential of graphene, with a particular interest in understanding and optimising the relationship between the manufacturing process and materials science. The partnership has been established to improve the prospects of bringing this material to commercial reality. Morgan initially began work with The University of Manchester in early 2010 on a number of Government-funded materials and related programmes, and the joint graphene development agreement represents the next stage in this relationship.

 

The University of Manchester, the home of graphene, was where the scientific discovery was made. It has around 200 graphene researchers and is a world leader in applied and fundamental graphene research. The £61m National Graphene Institute at the University is set to open in early 2015, funded by £38m from the Engineering and Physical Sciences Research Council and £23m from the European Regional Development Fund. The integrated Morgan and University academic team will therefore be working within a significant community of graphene expertise and facilities.

 

Dr Mike Murray, Chief Technology Officer of Morgan Advanced Materials commented: "With decades of expertise in developing specialist carbon-based materials, Morgan's material scientists will be based full time at the university, working closely with academic colleagues to understand the manufacturing mechanism and properties of graphene, helping us explore the applications where the technology can be used for optimum benefit."

Clive Rowland, CEO of the University's Innovation Company, UMI3, added: "To explore and fully exploit the properties of graphene, commercial partnerships are vital. I am very pleased with our collaboration with Morgan, which is based around an intellectual property project that we have taken to the proof-of-principle stage. We have consistently said that joining forces with world-class companies like Morgan Advanced Materials and tapping into such engineering and industrial experience will help us realise the full potential of the material and greatly assist us in overcoming the myriad challenges of taking an entirely new material from the laboratory all the way through to the manufacturing stage and ultimately to market adoption."

 

For more information on graphene visit www.graphene.manchester.ac.uk

 

Ends

 

 

Morgan Advanced Materials

Dr Mike Murray

020 7404 5959

 

Brunswick Group LLP

Nina Coad

Alison Kay

020 7404 5959

 

The University of Manchester

Daniel Cochlin

Graphene Communications and Marketing Manager

0161 275 8382

07917 506158

www.graphene.manchester.ac.uk 

www.manchester.ac.uk

Twitter: @UoMGraphene

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSSASAIFLSELA
Date   Source Headline
1st May 20245:38 pmRNSHolding(s) in Company
24th Apr 20247:00 amRNSCapital Markets Update
5th Apr 202412:55 pmRNSAnnual Financial Report
4th Apr 20241:16 pmRNSDirector/PDMR Shareholding
27th Mar 20244:52 pmRNSDirector/PDMR Shareholding
27th Mar 20244:50 pmRNSDirector/PDMR Shareholding
27th Mar 20244:49 pmRNSDirector/PDMR Shareholding
27th Mar 20244:48 pmRNSDirector/PDMR Shareholding
14th Mar 20249:42 amRNSDirector/PDMR Shareholding
14th Mar 20249:41 amRNSDirector/PDMR Shareholding
13th Mar 202412:10 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSMorgan Advanced Materials Full Year 2023 Results
27th Dec 20237:00 amRNSDirector/PDMR Shareholding
19th Dec 20231:56 pmRNSDirector/PDMR Shareholding
18th Dec 20234:25 pmRNSBlock listing Interim Review
22nd Nov 202310:07 amRNSDirector/PDMR Shareholding
9th Nov 20237:00 amRNSQ3 Trading Update
9th Oct 20234:43 pmRNSDirector/PDMR Shareholding
26th Sep 202312:24 pmRNSDirector/PDMR Shareholding
16th Aug 202311:27 amRNSDirector/PDMR Shareholding
7th Aug 20235:24 pmRNSDirector/PDMR Shareholding
4th Aug 20237:00 amRNSHalf-Year Results for Period Ended 30 June 2023
13th Jul 20234:49 pmRNSDirector/PDMR Shareholding
5th Jul 20234:51 pmRNSDirector/PDMR Shareholding
29th Jun 20235:06 pmRNSResult of AGM
29th Jun 20237:00 amRNSH1 Trading Update
22nd Jun 202311:50 amRNSBlock listing Interim Review
31st May 20233:52 pmRNSDirector/PDMR Shareholding
26th May 20233:28 pmRNSNotice of Annual General Meeting 2023
24th May 20233:59 pmRNSDirector/PDMR Shareholding
11th May 202312:06 pmRNSDirector/PDMR Shareholding
11th May 202312:01 pmRNSDirector/PDMR Shareholding
11th May 202311:59 amRNSDirector/PDMR Shareholding
9th May 20235:59 pmRNSDirector/PDMR Shareholding
4th May 20235:28 pmRNSAnnual Report & Accounts 2022
3rd May 20235:38 pmRNSDirector/PDMR Shareholding
3rd May 20235:28 pmRNSDirector/PDMR Shareholding
28th Apr 20235:45 pmRNSInformation required by DTR 4.1
28th Apr 20237:00 amRNSFull-year results for the period ended 31 Dec 2022
13th Apr 20237:00 amRNSNotification of Full-Year Results
7th Feb 20237:00 amRNSUpdate on Trading and Cyber Security Incident
18th Jan 20237:00 amRNSAppointment of Chair Designate
10th Jan 20237:00 amRNSNotice of Cyber Security Incident
22nd Dec 202211:01 amRNSBlock listing Interim Review
16th Dec 20224:44 pmRNSHolding(s) in Company
6th Dec 20227:00 amRNSAccelerated Pension Contribution
6th Dec 20227:00 amRNSCapital Markets Event
23rd Nov 202210:01 amRNSDirector/PDMR Shareholding
15th Nov 20225:06 pmRNSDirector/PDMR Shareholding
10th Nov 20228:03 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.